Scandinavian Medical Solutions (One-pager): Building the foundation for the next growth phase
We have updated our investment case one-pager following Scandinavian Medical Solutions’ H1 2023/24 report which was announced last week.
In the first half of the accounting year 2023/24, Scandinavian Medical Solutions reported revenue of DKK 102.6 million, corresponding to a growth of approximately 7% YoY. Looking at profitability, however, frontloaded investments to build the foundation for the next growth phase meant that EBITDA declined significantly to DKK 8.0m (DKK 14.4m in H1 2022/23). The decline is primarily driven by the growth investments, also shown by a gross margin that only fell marginally.
The company reiterated its full-year 2023/24 guidance with revenue expected to be between DKK 210-230m and EBITDA between DKK 20-23m.
For further details about the H1 2023/24 results, you can watch the management presentation with CEO Jens Hvid Paulsen and Head of Sales Martin Lind here: https://www.inderes.dk/videos/scandinavian-medical-solutions-praesentation-af-h1-20232024
Disclaimer: HC Andersen Capital receives payment from Scandinavian Medical Solutions for a Digital IR/Corporate Visibility subscription agreement. /Michael Friis 15:30, 21 May 2024.
Login required
This content is only available for logged in users
Scandinavian Medical Solutions
Scandinavian Medical Solutions är verksamt inom vård och omsorg. Bolaget är en dansk återförsäljare av bilddiagnostikutrustning. Produktutbudet inkluderar CT- och MR-skannrar samt ultraljudsenheter och röntgenutrustning. Bolaget bedriver sin försäljning globalt och kunderna återfinns främst bland sjukhus. Scandinavian Medical Solutions grundades 2019 och har sitt huvudkontor i Aalborg.
Read more on company page